Results 141 to 150 of about 174,772 (308)

2-Chloro-2-Deoxyadenosine—a Novel Immunosuppressive Agent

, 1993
NULL AUTHOR_ID
openalex   +1 more source

Preliminary guidelines for diagnosing and treating tuberculosis in patients with rheumatoid arthritis in immunosuppressive trials or being treated with biological agents [PDF]

, 2002
D E Furst, J. Cush, Stefan H. E. Kaufmann, J. Siegel, R. Kurth   +4 more
openalex   +1 more source

TSHR‐Targeting Nucleic Acid Aptamer Treats Graves' Ophthalmopathy via Novel Allosteric Inhibition

Advanced Science, EarlyView.
This study presents YC3, a novel inhibitory TSHR‐targeting aptamer, as a promising therapeutic for Graves' ophthalmopathy (GO). YC3 suppresses pathological phenotypes in human orbital fibroblasts and improves outcomes in GO mice by binding to a previously unidentified allosteric site on TSHR, demonstrating the potential of aptamers in advancing ...
Yanchen Zhang, Ende Wu, Weibin Liu, Ling Zeng, Neng Ling, Hongmei Wang, Zhixing Li, Shuang Yao, Tonghe Pan, Xuanwen Li, Yate Huang, Xiaojing Li, Yunhai Tu, Wentao Yan, Jianzhang Wu, Mao Ye, Wencan Wu   +16 more
wiley   +1 more source

The relationship between cumulative dose of immunosuppressive agents and COVID-19-associated mucormycosis: A multicenter cross-sectional study. [PDF]

Health Sci Rep, 2022
Rastkar M, SeyedAlinaghi S, Asanjarani B, Siri G, Abdollahi H, Ghadami L, Hasibi M, Khodashahi R, Bagheri A, Asadollahi-Amin A.   +9 more
europepmc   +1 more source

The transplanted child: New immunosuppressive agents and the need for pharmacokinetic monitoring [PDF]

, 2002
Guido Filler, Janusz Feber
openalex   +1 more source

tRNA‐Derived Fragment tRF‐22 Promotes Immunosuppression by Inhibiting HnRNPAB Ubiquitination in Esophageal Squamous Cell Carcinoma

Advanced Science, EarlyView.
tRF‐22 fosters an immunosuppressive and pro‐oncogenic tumor microenvironment in ESCC by stabilizing hnRNPAB against TRIM25‐mediated ubiquitination and enhancing TGFβ2 expression, which increases PMN‐MDSCs infiltration and suppresses CD8+ T cells. Targeting tRF‐22 or blocking TGFβ signalling improves anti‐PD1 response, offering a promising therapeutic ...
Ling Pan, Xin Qin, Li Gong, Haining Liu, Bo Cheng, Jing Wang, Yajie Hu, Lingxing Zeng, Yiping Wang, Qingxu Song, Yufeng Cheng   +10 more
wiley   +1 more source

Complications Associated with Immunosuppressive Agents in Solid Organ Transplant Recipients: A Nationwide Analysis. [PDF]

J Clin Med
Lee AY, Jeong J, Heo KN, Park S, Ah YM, Han JM, Lee JY, Min SI.   +7 more
europepmc   +1 more source

Toxoplasmosis in patients with an autoimmune disease and immunosuppressive agents: A multicenter study and literature review. [PDF]

PLoS Negl Trop Dis, 2022
Durieux MF, Lopez JG, Banjari M, Passebosc-Faure K, Brenier-Pinchart MP, Paris L, Gargala G, Berthier S, Bonhomme J, Chemla C, Villena I, Flori P, Fréalle E, L'Ollivier C, Lussac-Sorton F, Montoya JG, Cateau E, Pomares C, Simon L, Quinio D, Robert-Gangneux F, Yera H, Labriffe M, Fauchais AL, Dardé ML.   +24 more
europepmc   +1 more source

FK506 VERSUS CYCLOSPORINE AS PRIMARY IMMUNOSUPPRESSIVE AGENT FOR ORTHOTOPIC LIVER ALLOGRAFT RECIPIENTS HISTOLOGIC AND IMMUNOPATHOLOGIC OBSERVATIONS1

, 1993
Prodromos Hytiroglou, RICHARD LEE, Kavita Sharma, Neil D. Theise, MYRON SCHWARTZ, Charles M. Miller, Swan N. Thung   +6 more
openalex   +1 more source

Mycophenolate mofetil for systemic lupus erythematosus refractory to other immunosuppressive agents [PDF]

, 2002
Mohammed Yousuf Karim
openalex   +1 more source